Philip Mathew
Internal Medicine · Tempe, AZNPI 1134409782
Payments from drug & device makers
What this record shows
That places this record below the midpoint for internal medicine clinicians in AZ, where the typical reported total is $142.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
$4,140,033in research payments, 2019–2025
Across 75 payments — averaging $55,200 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$2.1M
- Novo Nordisk AS$1.3M
- Merck$714K
- Adlon Therapeutics L.p.$92K
- Takeda Pharmaceuticals U.S.A., Inc.$10K
How this compares
$0 in reported general payments places this provider in the 15th percentile of 2,212 internal medicine providers in Arizona.
Other internal medicine in Tempe
- Robert BloombergTempe$12K
- Frank LovecchioPhoenix$911K
- Nasser HajaigPhoenix$687K
- Rajesh JanardhananTucson$685K
- Mona SelejTucson$440K
- Kelly KrohnPhoenix$262K
- Jacque SokolovScottsdale$235K
- Paul StanderPhoenix$222K
- Howard GrossmanPhoenix$131K
- Christine HarterGlendale$127K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.